Literature DB >> 14456835

[Quantities and rates of excretion of the Rauwolfia alkaloid ajmaline following different methods of administration].

H KLEINSORGE, P GAIDA.   

Abstract

Entities:  

Keywords:  RAUWOLFIA/metabolism

Mesh:

Substances:

Year:  1961        PMID: 14456835

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


× No keyword cloud information.
  8 in total

1.  The pharmacokinetics and organ distribution of ajmaline and quindine in the mouse.

Authors:  H Iven
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-05       Impact factor: 3.000

2.  Pharmacokinetics and dromotropic activity of ajmaline in rats with hyperthyroidism.

Authors:  Y Hashimoto; M Yasuhara; A Kamiya; K Okumura; R Hori
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

3.  Metabolic disposition of ajmaline.

Authors:  C Köppel; J Tenczer; I Arndt
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Oct-Dec       Impact factor: 2.441

4.  Pharmacokinetics and antiarrhythmic efficacy of intravenous ajmaline in ventricular arrhythmia of acute onset.

Authors:  C Köppel; A Wagemann; F Martens
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Apr-Jun       Impact factor: 2.441

5.  Kinetics of ajmaline disposition and pharmacologic response in beagle dogs.

Authors:  M Yasuhara; Y Hashimoto; K Okumura; R Hori; T Sakurai; C Kawai
Journal:  J Pharmacokinet Biopharm       Date:  1987-02

6.  Ajmaline test in a patient with chronic renal failure. A pharmacokinetic and pharmacodynamic study.

Authors:  R Padrini; L Compostella; D Piovan; A Javarnaro; F Cucchini; M Ferrari
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

7.  Pharmacokinetics and electrophysiological effects of intravenous ajmaline.

Authors:  R Padrini; D Piovan; A Javarnaro; F Cucchini; M Ferrari
Journal:  Clin Pharmacokinet       Date:  1993-11       Impact factor: 6.447

8.  Pharmacokinetics and antiarrhythmic activity of ajmaline in rats subjected to coronary artery occlusion.

Authors:  Y Hashimoto; R Hori; K Okumura; M Yasuhara
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.